reviews on glp 1 for weight loss GLP-1 GIP Agonist Management GLP-1 medications are marketed to

Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)

If the provider determines that GLP-1 medication is appropriate, they consider which medication and starting dose is safest for you, what monitoring is needed, and what follow-up schedule is appropriate

Your doctor will recommend which drugs youll need to take for your blood sugar levels

Notably, formal recognition of class I obesity as an indication for surgery only emerged in Western guidelines in 2023 [24], and robust comparative cost-effectiveness data between ESG and MBS in this group are still limited, ESGs minimally invasive nature, favorable safety profile, and sustained effectiveness [10,17,18,19] support its consideration as a clinically and economically balanced option

Side effects can often be mitigated by correctly titrating your dosage upward, so youll want to ensure that you are taking the medication exactly as prescribed by your provider to minimize risk and/or severity of side effects

Action and Therapeutic Potential of Oxyntomodulin